FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.
KU Leuven and FIT Biotech today announced that they entered into a worldwide license and collaboration agreement for the development of novel immunotherapeutics based on FIT Biotech's proprietary Gene Transport Unit (GTU) technology for transient in vivo expression of monoclonal antibodies. The agreement provides KU Leuven with an exclusive worldwide license to six undisclosed proprietary antibodies or marketed recombinant products. read more
MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support the diagnosis and treatment of cancer patients, today announced that it has entered into agreements with MultiPlan and Three Rivers Provider Network (TRPN). The two agreements provide expanded access to the company's ConfirmMDx for Prostate Cancer test to the networks' combined 67 million covered lives within the United States. read more
The Altran Foundation for Innovation launches in Belgium its 2013 Award for safe, sustainable & healthy food. read more
Niqel Lda., a Mozambique based company active in the production of renewable energy from Jatropha curcas has signed a license and services agreement with QUINVITA. This agreement provides access to the QUINVITA advanced agronomy know how and to seed of the best QUINVITA (QVP) cultivars of Jatropha curcas. read more
MDxHealth SA (NYSE Euronext: MDXH) and Bostwick Laboratories, Inc. today announced that they have entered into a marketing agreement to commercialize MDxHealth's ConfirmMDx for Prostate Cancer test. Bostwick Laboratories is a national, full-service laboratory specializing in anatomic and clinical pathology, with a focus on uropathology. The agreement provides MDxHealth with access to one of the largest urology networks in the United States. read more
TiGenix NV (Euronext Brussels: TIG) announces today the successful completion of the EUR 6.5 million capital increase announced on July 17 and 18, 2013. In total, 26 million new shares were issued. read more